Literature DB >> 9016530

BTKbase, mutation database for X-linked agammaglobulinemia (XLA)

M Vihinen1, B H Belohradsky, R N Haire, E Holinski-Feder, S P Kwan, I Lappalainen, H Lehväslaiho, T Lester, A Meindl, H D Ochs, J Ollila, I Vorechovsky, M Weiss, C I Smith.   

Abstract

X-linked agammaglobulinemia (XLA) is an immunodeficiency caused by mutations in the gene coding for Bruton's agammaglobulinemia tyrosine kinase (BTK). A database (BTKbase) of BTK mutations has been compiled and the recent update lists 368 entries from 318 unrelated families showing 228 unique molecular events. In addition to mutations the database lists also some polymorphisms and site-directed mutations. Each patient is given a unique patient identity number (PIN). Information is provided regarding the phenotype including symptoms. Mutations in all the five domains of BTK have been noticed to cause the disease, the most common event being missense mutations. The mutations appear almost uniformly throughout the molecule and frequently affect CpG sites forming arginine residues. These hot spots have generally pyrimidines 5'and purines 3'to the mutated cytosine. A decreased frequency of missense mutations was found in the TH, SH3 and the upper lobe of the kinase domain. The putative structural implications of all the missense mutations are given in the database showing 228 unique molecular events, including a novel missense mutation causing an R28C substitution as previously seen in the Xid mouse.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016530      PMCID: PMC146405          DOI: 10.1093/nar/25.1.166

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  49 in total

1.  Expression of a novel form of Tec kinase in hematopoietic cells and mapping of the gene to chromosome 5 near Kit.

Authors:  H Mano; K Mano; B Tang; M Koehler; T Yi; D J Gilbert; N A Jenkins; N G Copeland; J N Ihle
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

2.  Structural studies on the PH domains of Db1, Sos1, IRS-1, and beta ARK1 and their differential binding to G beta gamma subunits.

Authors:  D Mahadevan; N Thanki; J Singh; P McPhie; D Zangrilli; L M Wang; C Guerrero; H LeVine; C Humblet; J Saldanha
Journal:  Biochemistry       Date:  1995-07-18       Impact factor: 3.162

3.  Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA).

Authors:  H Jin; A D Webster; M Vihinen; P Sideras; I Vorechovsky; L Hammarstróm; E Bernatowska-Matuszkiewicz; C I Smith; M Bobrow; D Vetrie
Journal:  Hum Mol Genet       Date:  1995-04       Impact factor: 6.150

4.  Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.

Authors:  D J Rawlings; D C Saffran; S Tsukada; D A Largaespada; J C Grimaldi; L Cohen; R N Mohr; J F Bazan; M Howard; N G Copeland
Journal:  Science       Date:  1993-07-16       Impact factor: 47.728

5.  Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.

Authors:  J D Thomas; P Sideras; C I Smith; I Vorechovský; V Chapman; W E Paul
Journal:  Science       Date:  1993-07-16       Impact factor: 47.728

6.  DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.

Authors:  I Vorechovský; M Vihinen; G de Saint Basile; S Honsová; L Hammarström; S Müller; L Nilsson; A Fischer; C I Smith
Journal:  Hum Mol Genet       Date:  1995-01       Impact factor: 6.150

7.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

Authors:  D Vetrie; I Vorechovský; P Sideras; J Holland; A Davies; F Flinter; L Hammarström; C Kinnon; R Levinsky; M Bobrow
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

8.  Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia.

Authors:  S Tsukada; D C Saffran; D J Rawlings; O Parolini; R C Allen; I Klisak; R S Sparkes; H Kubagawa; T Mohandas; S Quan
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

9.  Structural characterization of the interaction between a pleckstrin homology domain and phosphatidylinositol 4,5-bisphosphate.

Authors:  J E Harlan; H S Yoon; P J Hajduk; S W Fesik
Journal:  Biochemistry       Date:  1995-08-08       Impact factor: 3.162

10.  Mutational analysis of the pleckstrin homology domain of the beta-adrenergic receptor kinase. Differential effects on G beta gamma and phosphatidylinositol 4,5-bisphosphate binding.

Authors:  K Touhara; W J Koch; B E Hawes; R J Lefkowitz
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

View more
  15 in total

Review 1.  Early B cell defects.

Authors:  H B Gaspar; M E Conley
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

2.  Human Variome Project Quality Assessment Criteria for Variation Databases.

Authors:  Mauno Vihinen; John M Hancock; Donna R Maglott; Melissa J Landrum; Gerard C P Schaafsma; Peter Taschner
Journal:  Hum Mutat       Date:  2016-03-21       Impact factor: 4.878

Review 3.  X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase.

Authors:  C I Smith; C M Bäckesjö; A Berglöf; L J Brandén; T Islam; P T Mattsson; A J Mohamed; S Müller; B Nore; M Vihinen
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Btk dosage determines sensitivity to B cell antigen receptor cross-linking.

Authors:  A B Satterthwaite; H Cheroutre; W N Khan; P Sideras; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

5.  Regulation of nucleocytoplasmic shuttling of Bruton's tyrosine kinase (Btk) through a novel SH3-dependent interaction with ankyrin repeat domain 54 (ANKRD54).

Authors:  Manuela O Gustafsson; Alamdar Hussain; Dara K Mohammad; Abdalla J Mohamed; Vivian Nguyen; Pavel Metalnikov; Karen Colwill; Tony Pawson; C I Edvard Smith; Beston F Nore
Journal:  Mol Cell Biol       Date:  2012-04-23       Impact factor: 4.272

6.  Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase.

Authors:  C D Novina; S Kumar; U Bajpai; V Cheriyath; K Zhang; S Pillai; H H Wortis; A L Roy
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

7.  BTKbase, mutation database for X-linked agammaglobulinemia (XLA).

Authors:  M Vihinen; O Brandau; L J Brandén; S P Kwan; I Lappalainen; T Lester; J G Noordzij; H D Ochs; J Ollila; S M Pienaar; P Riikonen; B K Saha; C I Smith
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

8.  Achieving a Graded Immune Response: BTK Adopts a Range of Active/Inactive Conformations Dictated by Multiple Interdomain Contacts.

Authors:  Raji E Joseph; Thomas E Wales; D Bruce Fulton; John R Engen; Amy H Andreotti
Journal:  Structure       Date:  2017-08-31       Impact factor: 5.006

Review 9.  Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.

Authors:  Conor Gruber; Dusan Bogunovic
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

10.  Mutation of the BTK gene and clinical feature of X-linked agammaglobulinemia in mainland China.

Authors:  Ying Wang; Hirokazu Kanegane; Xiaochuan Wang; Xiaohua Han; Qian Zhang; Shunying Zhao; Yeheng Yu; Jingyi Wang; Toshio Miyawaki
Journal:  J Clin Immunol       Date:  2008-11-28       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.